Lannett (LCI) Stock Price, News & Analysis

Company Overview

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.65 to $2.51
• 52-Week Range: N/A
• Volume: 280,600 shs
• Average Volume: 92,067 shs
• Market Capitalization: $7.38 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LCI Stock Analysis - Frequently Asked Questions

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) announced its earnings results on Wednesday, November, 3rd. The company reported ($1.08) EPS for the quarter, missing the consensus estimate of ($1.00) by $0.08. The firm had revenue of $101.53 million for the quarter, compared to the consensus estimate of $98.62 million.
Read the conference call transcript.

When did Lannett's stock split?

Shares of Lannett reverse split on Tuesday, February 7th 2023.The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lannett investors own include Bristol Myers Squibb (BMY), Akorn (AKRX), Micron Technology (MU), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), AT&T (T) and Bank of America (BAC).

Company Calendar

• Last Earnings: 11/03/2021
• Today: 8/17/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceuticals
• Current Symbol: NYSE:LCI
• CIK: 57725
• Web: www.lannett.com
• Phone: (215) 333-9000
• Fax: 215-333-9004
• Employees: 810
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($18.88)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$231.62 million
• Net Margins: -62.40%
• Pretax Margin: -62.67%
• Return on Equity: N/A
• Return on Assets: -13.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.23
• Quick Ratio: 1.39

Sales & Book Value

• Annual Sales: $340.58 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($23.34) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 10,770,000
• Free Float: 9,354,000
• Market Cap: $7.38 million
• Optionable: Optionable
• Beta: 0.95